Thomas Hartung's guest appearances

Thomas Hartung

Finding Genius Podcast

Narices Humedas

FutureTech Podcast

Politik oder Popcorn?

Laura Potterat

Marc Guell

Paul Turner

Jan Vijg

Eleftherios Mylonakis

Cory Kidd

Charles C.J

Helius Medical Technologies

Patrick McKeown

Michael G. Surette

Katelyn Parsons

John Tucker

Jake Kushner

Erik Gunther

Kim Kush

OwlTail

In dieser Folge von "Politik oder Popcorn?" haben wir einen Gast in unserer Runde: Dr. Thomas Hartung ist nicht nur, wie Diana und Lutz, Abgeordneter der SPD im Thüringer Landtag, sondern auch praktizierender Arzt. Gemeinsam mit ihm sprechen die beiden über alles was die Corona-Impfung betrifft und welche Maßnahmen jetzt getroffen werden, damit wir einen guten Sommer erleben können. Ein wirklich guter Einblick durch unseren "Karl Lauterbach der Fraktion".

In dieser Folge von "Politik oder Popcorn?" haben wir einen Gast in unserer Runde: Dr. Thomas Hartung ist nicht nur, wie Diana und Lutz, Abgeordneter der SPD im Thüringer Landtag, sondern auch praktizierender Arzt. Gemeinsam mit ihm sprechen die beiden über alles was die Corona-Impfung betrifft und welche Maßnahmen jetzt getroffen werden, damit wir einen guten Sommer erleben können. Ein wirklich guter Einblick durch unseren "Karl Lauterbach der Fraktion".

Folge 4 - #Ärmelhoch! Die Spezialfolge übers Impfen mit Dr. Thomas Hartung

In this podcast, Dr. Thomas Hartung of the Johns Hopkins Bloomberg School of Public Health, talks about organoids and the cellular-based technologies. Dr. Hartung has a storied career in research. He is actively involved in the work being done at the Environmental Health and Engineering, and Molecular Microbiology and Immunology departments at the world-renowned Johns Hopkins Bloomberg School of Public Health. His work is intimately connected to the creation of a major paradigm shift in toxicity testing with the goal of improving public health. His involvement with the 2007 NRC vision document known as, “Toxicity Testing in the 21st Century – a vision and a strategy” has played a key role in elevating the discourse. Dr. Hartung discusses his intensive work in the areas of toxicity and animal testing, as well as genomics and metabolomics. He talks in detail about the ‘organ on a chip’ technology, a field that he states is permanently moving and progressing. He discusses the advancement of organoids (tiny, self-organized 3D tissue cultures created from stem cells), and the importance of toxicity testing. The Johns Hopkins research doctor talks about tissue technology and cellular communication as he discusses nutrients, cell types, and the evolving research. Dr. Hartung explains that the ‘human on a chip’ technologies will change as more research is done. Organoids are currently being used to test compounds to study the toxicity, but modeling diseases is another avenue of study. One obvious outcome that would be beneficial if achieved would be the elimination of animal testing altogether.

In this podcast, Dr. Thomas Hartung of the Johns Hopkins Bloomberg School of Public Health, talks about organoids and the cellular-based technologies. Dr. Hartung has a storied career in research. He is actively involved in the work being done at the Environmental Health and Engineering, and Molecular Microbiology and Immunology departments at the world-renowned Johns Hopkins Bloomberg School of Public Health. His work is intimately connected to the creation of a major paradigm shift in toxicity testing with the goal of improving public health. His involvement with the 2007 NRC vision document known as, “Toxicity Testing in the 21st Century – a vision and a strategy” has played a key role in elevating the discourse. Dr. Hartung discusses his intensive work in the areas of toxicity and animal testing, as well as <a href="https://www.futuretechhealth.com/podcasts/amassing-standardizing-genomic-data-useful-comparisons-data-driven-medicine-kevin-puylaert-sophia-genetics/" rel="nofollow" target="_blank">genomics</a> and metabolomics. He talks in detail about the ‘organ on a chip’ technology, a field that he states is permanently moving and progressing. He discusses the advancement of organoids (tiny, self-organized 3D tissue cultures created from stem cells), and the importance of toxicity testing. The Johns Hopkins research doctor talks about tissue technology and cellular communication as he discusses nutrients, cell types, and the evolving research. Dr. Hartung explains that the ‘human on a chip’ technologies will change as more research is done. Organoids are currently being used to test compounds to study the toxicity, but modeling diseases is another avenue of study. One obvious outcome that would be beneficial if achieved would be the elimination of animal testing altogether.

Testing for Toxins & Disease Modeling – Dr. Thomas Hartung

Johns Hopkins Bloomberg

Thomas Hartung, MD, Johns Hopkins Bloomberg School of Public Health, delivers an insightful overview of his work studying toxicity testing improvements, organoids, and advancing technologies. Dr. Hartung has departmental affiliations with the Environmental Health and Engineering and Molecular Microbiology and Immunology departments at Johns Hopkins. Dr. Hartung’s work is heavily focused on creating a paradigm shift in toxicity testing to improve overall public health. Dr. Hartung has been an integral part of the implementation of the 2007 NRC vision document known as, “Toxicity Testing in the 21st Century – a vision and a strategy.” Dr. Hartung discusses his background, and the road he has taken to arrive at his current place as a leading voice in the discussions concerning toxicity and animal testing. He explains that the technological opportunities have advanced significantly in the last few years. Dr. Hartung discusses ‘organ on a chip’ technologies and other advanced tissue, etc. work. As he explains, this field is permanently moving. The advancement of organoids, which are small, self-organized 3D tissue cultures that are actually derived from stem cells, is changing the way research is done. The research doctor talks about the importance of toxicity testing, cellular communication and tissue technology, as well as genomics and metabolomics, discussing nutrients, types of cells, and the coming research that will certainly advance the field. Learning from current experiences, he explains that the ‘human on a chip’ technologies will continue to change as more research is done. Organoids are being used to test various compounds to observe the relative toxicity, but they are utilized for other reasons as well, such as modeling diseases. As Dr. Hartung states, the future will likely bring these types of systems into all kinds of toxicity testing, and replace animal testing altogether if possible.

Thomas Hartung, MD, Johns Hopkins Bloomberg School of Public Health, delivers an insightful overview of his work studying toxicity testing improvements, organoids, and advancing technologies. Dr. Hartung has departmental affiliations with the Environmental Health and Engineering and Molecular Microbiology and Immunology departments at Johns Hopkins. Dr. Hartung’s work is heavily focused on creating a paradigm shift in toxicity testing to improve overall public health. Dr. Hartung has been an integral part of the implementation of the 2007 NRC vision document known as, “Toxicity Testing in the 21st Century – a vision and a strategy.” Dr. Hartung discusses his background, and the road he has taken to arrive at his current place as a leading voice in the discussions concerning toxicity and animal testing. He explains that the technological opportunities have advanced significantly in the last few years. Dr. Hartung discusses ‘organ on a chip’ technologies and other advanced tissue, etc. work. As he explains, this field is permanently moving. The advancement of organoids, which are small, self-organized 3D tissue cultures that are actually derived from stem cells, is changing the way research is done. The research doctor talks about the importance of toxicity testing, cellular communication and tissue technology, as well as <a href="https://www.futuretechpodcast.com/podcasts/creating-a-source-of-collective-knowledge-and-applying-genomics-to-advance-the-medical-field-dr-rakesh-nagarajan-m-d-ph-d-pieriandx/" rel="nofollow" target="_blank">genomics</a> and <a href="https://www.futuretechpodcast.com/podcasts/clinical-metabolomics-metabolites-as-diagnostic-tools-and-the-potential-for-novel-treatments-martin-giera-phd-associate-professor-at-leiden-university/" rel="nofollow" target="_blank">metabolomics</a>, discussing nutrients, types of cells, and the coming research that will certainly advance the field. Learning from current experiences, he explains that the ‘human on a chip’ technologies will continue to change as more research is done. Organoids are being used to test various compounds to observe the relative toxicity, but they are utilized for other reasons as well, such as modeling diseases. As Dr. Hartung states, the future will likely bring these types of systems into all kinds of toxicity testing, and replace animal testing altogether if possible.

Toxicity & Disease – Thomas Hartung, MD, Johns Hopkins Bloomberg School of Public Health – New Technology Advances to Improve Toxicity Testing and Disease Modeling